Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.88% | 34.09% | |||
| Gross Profit | -0.88% | -57.79% | |||
| SG&A Expenses | -4.79% | 3.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.60% | 18.99% | |||
| Operating Income | 1.60% | -28.67% | |||
| Income Before Tax | 3.70% | 60.47% | |||
| Income Tax Expenses | 13.68% | -85.06% | |||
| Earnings from Continuing Operations | 3.61% | 60.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.61% | 60.78% | |||
| EBIT | 1.60% | -28.67% | |||
| EBITDA | 1.55% | -31.65% | |||
| EPS Basic | 36.55% | 68.17% | |||
| Normalized Basic EPS | 36.60% | -6.45% | |||
| EPS Diluted | 36.55% | 68.17% | |||
| Normalized Diluted EPS | 36.60% | -6.45% | |||
| Average Basic Shares Outstanding | 51.90% | 23.19% | |||
| Average Diluted Shares Outstanding | 51.90% | 23.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||